Le p300/CBP acétyltransférase est un co-activateur transcriptionnel très important qui est impliqué dans la régulation d'un grand nombre de processus biologiques, comme la transcription d'ADN, le développement et l'immunité innée. Jusqu'à présent, le rôle de p300/CBP dans la régulation de l'expression des gènes a été largement étudiée, mais les mécanismes qui régulent son activité enzymatique sont encore peu connus. Des études ont montré que le dysfonctionnement de p300/CBP est associé à plusieurs formes de cancer et de maladies neurodégénératives. Dés lors, chaque progrès concernant les mécanismes de régulation de p300/CBP est devenu primordial pour le développement de nouvelles thérapies. Le 'noyau' de p300/CBP contient deux domaines pour la reconnaissance des modifications post-traductionnelles (MPTs), un bromodomaine et un PHD finger (le module BP), adjacent à un domaine HAT (ou domaine histone acétyltransférase). Plusieurs enzymes, modifiant la chromatine, contiennent des domaines de reconnaissance des MPTs. Fréquemment des groupements particuliers de ces domaines sont très conservés et liés, au sein de la même protéine ou du même complexe protéique, suggérant qu'ils réalisent des fonctions coordonnées. Ces domaines adjacents peuvent agir en concertation dans la reconnaissance simultanée de différents MPTs ou peuvent exercer des fonctions différentes de celles qui sont effectuées par ces deux domaines particuliers, tels que les fonctions de régulation enzymatique. Plusieurs études suggèrent que les cycles acétylation/désacétylation dans la boucle d'auto-inhibition, à l'intérieur du domaine HAT, jouent un rôle important dans la régulation de l'activité enzymatique de p300/CBP. La proximité du module BP et du domaine HAT suggère que la spécificité de liaison, appartenant au module BP, peut être intrinsèquement liée à la régulation de l'activité du domaine HAT. L'objectif de ma thèse est de déterminer le rôle du module BP dans la régulation de l'activité du domaine HAT. Je propose que le module BP soit impliqué dans la régulation de p300/CBP de deux façons. La première consiste à établir un lien avec le domaine HAT qui stabilise la conformation auto-inhibée de l'enzyme. La deuxième exige que le module BP joue un rôle dans le choix des substrats de p300/CBP. J'ai été en mesure de montrer que BP peut se lier au domaine HAT et à la chromatine modifiée et qu'il peut reconnaître les modifications effectuées par p300/CBP lui-même. Les données obtenues indiquent que le module BP peut être impliqué dans la régulation de l'activité de p300/CBP et dans son ciblage à la chromatine. / The p300/CBP acetyltransferase is an important transcriptional co-activator which is involved in regulating a wide range of biological processes, such as DNA transcription, development and innate immunity. To date, the role of p300/CBP in gene regulation has been extensively described but little is known about the mechanisms which regulate its activity. Since misregulation of p300/CBP has been associated to the development of several forms of cancers and neurodegenerative diseases, studies directed to decipher the mechanisms of regulation of p300/CBP are of great importance for the development of new therapies. The p300/CBP 'core' contains two post-translational modifications (PTMs) recognition motifs, a bromodomain and a PHD domain (the bromo-PHD module, BP), in close proximity to a histone acetyltransferase domain (HAT). Many chromatin modifying enzymes contain recognition modules for PTMs. Frequently particular groupings of such modules are conserved and linked within the same protein or the same multisubunit complex, suggesting that they perform concerted functions. These linked modules may act combinatorially to allow recognition of multiple PTMs or display new functions that are not possessed by the single modules, such as regulatory properties. Accumulating evidence suggests that acetylation/deacetylation in a conserved autoinhibitory loop of the p300/CBP HAT domain plays an important role in regulation of HAT activity. The close apposition of the BP module and the HAT domain suggests that BP substrate recognition is intrinsically linked to regulation of HAT activity. During my thesis work, I have investigated the role of BP in HAT regulation. I propose that the BP module is involved in p300/CBP regulation by binding to the HAT domain and stabilizing the autoinhibited conformation of the enzyme. I have also investigated substrate specificity of the BP module towards modified chromatin. I could show that the BP module binds histone modifications including those that are p300/CBP dependent. Altogether, the data suggests that the BP module is involved in regulating p300/CBP HAT activity and in targeting of chromatin.

In S. cerevisiae initiation of replication occurs from discrete sites in the genome, known as origins and these display a characteristic temporal profile of activation during S phase of the cell cycle. The genomic context of origins has been demonstrated to be important to determine the time of firing, more specifically histone acetylation levels surrounding origins can influence their activation time. How increased acetylation is translated into earlier firing of specific origins is currently unknown. Bromodomains are known to bind acetylated histones in vivo. The bromodomain-containing Yta7p has been identified in a complex with various remodelers of chromatin and subunits of DNA polymerase ǫ. It is also a target of cell cycle and checkpoint kinases. Therefore, Yta7p makes an excellent candidate to bind acetylated histones surrounding replication origins and affect an alteration in the chromatin structure that could influence time of firing. Deletion of the histone deacetylase RPD3 results in a rapid S phase phenotype due to increased histone acetylation at “late-firing” origins. Increased acetylation at “late” origins leads to an advance in the time of firing of those specific origins. The aim of this study was to investigate the hypothesis that the bromodomain-containing protein Yta7p binds to histones with increased acetylation near to replication origins and subsequently influences origin firing. Hence, deletion of YTA7 would abolish the rapid S phase of a ∆rpd3 strain. Indeed the S phase of the ∆rpd3∆yta7 strain was reverted to WT duration. A role for Yta7p in DNA replication is also inferred by two additional lines of evidence presented in this thesis. Synthetic growth defects are evident when YTA7 and RPD3 deletion is combined with mutation of a third replication protein. In addition, ∆rpd3∆yta7 mutants are sensitive to HU, which is a phenotype shared by many strains with deletions in genes that encode proteins involved in DNA replication. Evidence to support a direct role of Yta7p in DNA replication events is provided by identification of an S phase specific binding of Yta7p to replication origins. Moreover, levels of Yta7p bound to early-firing origins are increased compared with their later-firing counterparts. Levels of Yta7p that are bound to “late-firing” origins are only increased in conditions of RPD3 deletion, where the resulting increase in histone acetylation at the “late-firing” origins is associated with advanced time of firing. Time of Yta7p binding at these “late” origins is also advanced concomitantly. This data supports the hypothesis that Yta7p provides a functional link between histone acetylation and time of origin activation. In searching for a specific replication linked function of Yta7p it was observed that recruitment of the FACT subunit Spt16p to replication origins was increased in conditions of YTA7 deletion. A second function for Yta7p in the S phase checkpoint was also demonstrated and the two roles of Yta7p, in DNA replication and S phase checkpoint, were separated depending upon their requirement for the bromodomain. The data produced in this thesis adds to our knowledge of DNA replication events and highlights the importance of histone modifications and chromatin remodeling to the replication field. This thesis describes the direct involvement of a protein, which was previously unassociated, with DNA replication and S phase checkpoint function and provides good ground work for future investigation.

Social stress is the most common stressor experienced by humans and exposure to social stress is thought to cause or exacerbate neuropsychiatric illness. Social stress also leads to behavioral and physiological responses in many animal models that closely mirror the symptoms of fear and anxiety in humans. Our laboratory uses Syrian hamsters to study behavioral responses to social stress. Hamsters are highly territorial, but after losing an agonistic encounter, hamsters exhibit a striking behavioral change, abandoning all territorial aggression and instead becoming highly submissive. This behavioral shift is termed conditioned defeat. Epigenetic modifications, such as changes in histone acetylation, are a possible molecular mechanism underlying such behavioral shifts. Histone deacetylase (HDAC) inhibitors have been shown to enhance fear learning and conditioned place preference for drugs of abuse, while suppressing histone acetylation with histone acetyltransferase (HAT) inhibitors impairs long-term memory formation. The first goal of this study was to test the hypothesis that histone acetylation is a molecular mechanism underlying conditioned defeat. We found that animals given an HDAC inhibitor systemically before social defeat later exhibited increased conditioned defeat. This treatment also suppressed defeat-induced immediate-early gene activity in the infralimbic cortex but not the basolateral amygdala. Next, we demonstrated that administration of an HDAC inhibitor in the infralimbic cortex before defeat enhanced stress-induced behavioral responses while HAT inhibition blocked these behavioral changes. Although both males and females exhibit conditioned defeat, the behavioral expression is more pronounced in males. We next used transcriptomic analysis to investigate potential genetic mechanisms leading to this sexually dimorphic expression and to further delineate the role of acetylation in stress-induced behavioral changes. We sequenced the whole brain transcriptome of male and female hamsters as well as the transcriptome of basolateral amygdala, a nucleus necessary for the acquisition and expression of conditioned defeat, of dominant, subordinate, and control animals. Our analysis revealed that numerous genes relating to histone acetylation, including several HDACs, were differentially expressed in animals of different social status and between sexes. Together, these data support the hypotheses that histone modifications underlie behavioral responses to social stress and that some of these modifications are sexually dimorphic.

Mechanical ventilation, a lifesaving intervention for patients with acute respiratory distress syndrome (ARDS), also unfortunately contributes to excessive mechanical stress and impaired lung physiological and structural integrity. We have elsewhere established the pivotal role of increased nicotinamide phosphoribosyltransferase (NAMPT) transcription and secretion as well as its direct binding to the toll-like receptor 4 (TLR4) in the progression of this devastating syndrome; however, regulation of this critical gene in ventilator-induced lung injury (VILI) is not well characterized. On the basis of an emerging role for epigenetics in enrichment of VILI and CpG sites within the NAMPT promoter and 5'UTR, we hypothesized that NAMPT expression and downstream transcriptional events are influenced by epigenetic mechanisms. Concomitantly, excessive mechanical stress of human pulmonary artery endothelial cells or lipopolysaccharide (LPS) treatment led to both reduced DNA methylation levels in the NAMPT promoter and increased gene transcription. Histone deacetylase inhibition by trichostatin A or Sirt-1-silencing RNA attenuates LPS-induced NAMPT expression. Furthermore, recombinant NAMPT administration induced TLR4-dependent global H3K9 hypoacetylation. These studies suggest a complex epigenetic regulatory network of NAMPT in VILI and ARDS and open novel strategies for combating VILI and ARDS.

<p>Identifying metabolic vulnerabilities of cancer cells remains a subject of investigation for the identification of potential metabolically based therapies for cancer. It is well known that proliferating cells become largely dependent on glucose and glutamine for their growth. Interestingly, we find that lipid oxidizing genes are consistently downregulated across a wide variety of cancers while lipid synthesizing genes are elevated. This indicates that lipid oxidation may be refractory to cancer cell growth. Studies have shown beneficial effects of carbohydrate restriction in various forms in the treatment of cancer. For example, the use of ketogenic diets, which contain high levels of fat and protein with very low levels of carbohydrates, have shown efficacy in decreasing tumor growth in glioma, colon, prostate, and gastric cancers. A major challenge facing the use of these diets in cancer therapy is that the mechanism by which they show efficacy in cancer remains unclear. By using octanoate, the most well-known ketogenic fatty acid, we are able to drive fatty acid oxidation and ketogenesis to study these processes in proliferating cells. We found that supplementation of octanoate into complete culture medium causes a dramatic, dose-dependent and reversible suppression of proliferation across numerous cell lines and significant changes to anabolic cellular metabolism. Importantly, we have found that ketone production from octanoate had no effect on cell proliferation but that the overall cellular response to the lipid causes inhibition of cell growth.</p><p>Nutrients and metabolites are sensed by the cell at many levels and the cellular response to metabolites is critical to proliferation and survival of a cancer cell. One way in which the cell responds to glucose, the major fuel source in cancer cells, is by increasing histone acetylation to promote gene expression. Wellen et al., found that upon glucose addition there was a specific gene expression pattern characterized by the upregulation of genes involved in glucose metabolism. In this way the cell promotes glucose-derived fatty acid synthesis, a rate-limiting process for cancer cell proliferation. This is one way in which the metabolic response to nutrients is integrated into cellular signaling and the epigenome. Remarkably, we have found that lipids can promote a feed-forward mechanism of lipid metabolism by inducing histone acetylation and increasing gene expression of lipid metabolizing genes. We find that upon treatment of cells with octanoate there is an inhibition of both glucose and glutamine metabolism and that octanoate-derived carbon becomes the major fuel source in the cell. We then found that histones were hyperacetylated after octanoate treatment and remarkably, close to 90% of the carbon on histones was octanoate derived. In addition, octanoate is a weak HDAC inhibitor which further promotes octanoate-derived acetyl-CoA being deposited onto histones. A gene array from octanoate treated samples finds that fatty acid metabolism is the top pathway in our gene ontology analysis. This provides evidence that the cell responds to nutrient sources in a specific manner depending on the nature of the carbon source. Finally, we find the most negatively regulated pathway upon octanoate treatment is DNA replication. Consistently, we find that octanoate causes an accumulation of cells in G1 phase of the cell cycle and induction of apoptosis.</p><p>Here we describe a mechanism for how fatty acids are sensed and how they communicate with the nucleus to alter gene expression. We show that the cell responds to lipids via a coordinated response to promote lipid metabolism and induce histone acetylation. This feed-forward mechanism of lipid metabolism consists of a reprograming of anabolic metabolism, and promotion of gene expression changes culminating in inhibition of cell growth and apoptosis.</p> / Dissertation

During cell activation the tightly compacted DNA is made available to DNA-binding proteins allowing the induction of gene transcription. In the resting cell, DNA is packaged into chromatin whose fundamental subunit is the nucleosome, composed of an octamer of four core histones (H) 3, 4, 2A and 2B. During the induction of gene transcription, modification of histones, by acetylation, methylation etc., results in unwinding of the DNA, permitting access of large DNAbinding proteins, such as RNA polymerase II, and subsequent induction of gene transcription. This investigation initially examined the effects of pro-inflammatory stimuli LPS and TNF-a on the production of IL-8 in a macrophage cell line (U937 cells) and in two T-cell lines (Jurkat and HUT-78 cells) as a marker of NF-KB-directed inflammatory gene expression. The ability of dexamethasone (Dex) and triamcinolone acetonide (TA) (synthetic glucocorticoid agonists) to suppress expression of the inflammatory cytokine IL-8 and to regulate histone acetylation was also investigated in these cells. LPS and TNF-a caused an increase in IL-8 expression, which was further enhanced by the histone deacetylases inhibitor trichostatin A (TSA), suggesting a role for histone acetylation in IL-8 production in these cells. Dex and TA, repressed LPS- and TNF-a -induced IL-8 expression in all three cell lines. This effect of both Dex and TA was attenuated by TSA in all cell lines studied, where the effect of TSA was greater in TA stimulated cells. Stimulation of all cell lines with LPS and TNF-a induced acetylation of H4 lysine residues (K5, 8, 12 and 16), the highest elevation of which was for K8 and K12. Also demonstrate is a K5 and K16 specificity of acetylation by glucocorticoids, apparent in all cell lines studied. Dex and, to a greater extent, TA suppressed LPS- and TNFa-induced K8 and K12 acetylation. TSA attenuated the inhibitory effect of the glucocorticoids for all three cell lines. An inCrease in HDAC activity with GCs was observed and ChiP assay showed these events occur on the native IL-8 promoter via histone acetylation. Further studies investigated whether there were any links between histone acetylation and the regulation of apoptosis. It was showed that TSA induced apoptosis in cells previously stimulated with the inducer of oxidative stress hydrogen peroxide (H20 2). Studies into the activation of caspase 3 in LPS- and TNF-a stimulated cells revealed that the combinatory effect of Dex or TA with TSA Significantly enhanced expression of the marker in all three cell lines. In resting cells, Dex, and TA, in the presence of TSA downregulated caspase 3 expression. These findings support the notion that glucocorticoid actions on apoptosis is mediated, at least in part, through an action on histone acetylation. Finally, histone acetylation was investigated in vivo in two rat models of inflammation and in human subjects with inflammatory bowel disease (IBD). The results showed an increase in histone H4 acetylation lysine specificity of acetylation on K8 and K12 in inflamed tissue and Peyer's patches in animal models and in IBD patients. Whereas H3 acetylation was not elevated to the same extent in tissue and was restricted to the mantle zone of Peyer's patches. In general, the present studies on histone acetylation and inflammation (in animal models and IBD patients) underlined the possibility of a general mechanism linking activation of the transcription factor NFKB with histone acetylation. The ultimate objective of this work is to aid in the understanding of the mechanisms of how deregulation of chromosome structure leads to progression of the disease state. This knowledge may aid in the development of new therapeutic approaches or improved glucocorticoids.

O (-)-?-bisabolol é um produto natural abundante na natureza, possui atividades biológicas reconhecidas, que o torna extremamente interessante para as indústrias de cosméticos e fármacos. Este trabalho tem como objetivo à preparação de novos compostos com possíveis aplicações biológicas, agregando valor ao produto natural. Durante as transformações procura-se trabalhar com metodologias ecologicamente corretas (Green Chemistry). O trabalho foi dividido em 4 (quatro) partes principais: oxidação, cicloadição, alquilação e acetilação. A oxidação alílica do (-)-?-bisabolol usando trióxido de cromo (CrO3) forneceu o Deodarone (tetraidro-2,2,6-trimetil-6-(4-metil-3-cicloexen-1-il)-4H-piran-4-ona) com 45,3% de rendimento. A cicloadição [1+2] entre diclorocarbeno e o (-)-?-bisabolol usando CETABr ou KF/Al2O3 originou o 4-(2,2-dicloro-3,3-dimetilciclopropil)-2- (7,7-dicloro-6-metilbiciclo[4.1.0]hept-3-il)-2-butanol com rendimentos de 92% e 97% respectivamente. A alquilação do álcool benzílico com o produto resultante da cicloadição gerou o 4-((2,2-bis(benzilóxi)-3,3-dimetilciclopropil)-2-(7,7- bis(benzilóxi))-6-metillbiciclo[4.1.0]heptan-3-il)butan-2-ol, o rendimento obtido foi de 92%. A epoxidação do (-)-?-bisabolol forneceu o Óxido de Bisabolol B: 1-metil- 1-[5-(4-metil-3-cicloexenil)tetraidro-2-furanil]etil álcool com rendimento de 30%. A acetilação do (-)-?-bisabolol utilizando DMAP ou ZnCl2 forneceu o 2-acetil-(S)-2- metil-2-((R)-4-metillciclohex-3-enil)hept-5-eno com rendimentos de 72,6% e 76,5% respectivamente. Os resultados obtidos foram bastante promissores e podem ser expandidos para trabalhar com outros grupos de moléculas com atividades biológicas. Todos os compostos foram caracterizados por RMN13C (apt). / The (-)-?-bisabolol is a natural product abundant in nature, it has recognized biological activities, which makes it very interesting for the cosmetic and pharmaceutical products. This work aims to prepare new compounds with potential biological applications, adding value to natural product. During the transformation we seek to work with eco-friendly methodologies (Green Chemistry). The work was divided into four (4) main parts: oxidation, cycloaddition, alkylation and acetylation. The allylic oxidation of (-)-?-bisabolol using chromium trioxide (CrO3) provided Deodarone (tetrahydro-2,2,6-trimethyl-6-(4-methyl-3- cicloexen-1-yl)-4H-pyran-4-one) with 45,3% yield. The cycloaddition [1+2] between dichlorocarbene and (-)-?-bisabolol using CETABr or KF/Al2O3 afforded the 4 - (2,2-dichloro-3 ,3-dimethylcyclopropyl) -2 - (7,7-dichloro-6-methylbicyclo [4.1.0] hept-3-yl)-2-butanol with yields of 92% and 97% respectively. Alkylation of benzyl alcohol with the product resulting from cycloaddition generated the 4-(2,2-bis (benzyloxi)-3,3-dimethylcyclopropil)-2-(7,7-bis(benzyloxi)) - 6 - methylbicycle[4.1.0] heptan-3-il)butan-2-ol, the yield was 92%. The epoxidation of (-)-?-bisabolol provided the Bisabolol Oxide B: 1-methyl-1-[5- (4-methyl-3-cicloexenil) tetrahydro- 2-furanyl] ethyl alcohol with yield of 30%. Acetylation of (-)-?-bisabolol using DMAP or ZnCl2 gave the 2-acetyl-(S)-2-methyl-2-((R)-4-metillciclohex-3-enyl) hept- 5-en with yields of 72,6% and 76,5% respectively. The results were very promising and can be expanded to work with others groups of molecules with biological activities. All compounds were characterized by RMN 13C (apt).

Listeria monocytogenes est l'un des meilleurs organismes modèles pour l'étude des interactions bactérie-hôte. Ce pathogène intracellulaire facultatif peut infecter, survivre et se répliquer dans le cytoplasme des cellules eucaryotes, démontrant la co-évolution étroite de Listeria avec son hôte. Le style de vie intracellulaire de ce pathogène implique la manipulation de divers composants de la cellule hôte, dont l'un est la chromatine. En induisant des modifications de la chromatine au niveau des histones, Listeria peut influencer le programme transcriptionnel de l'hôte. Ce projet de thèse porte sur une modification spécifique des histones, la désacétylation de la lysine 18 de l'histone H3, induite par la désacétylase de l'hôte Sirtuin 2 (SIRT2) lors de sa relocalisation du cytoplasme vers le noyau pendant l'infection. Le détournement de SIRT2 par Listeria fournit un système idéal pour étudier les mécanismes de la localisation subcellulaire de SIRT2, qui est mal comprise, et c'est le but de cette thèse. En utilisant la spectrométrie de masse, nous avons identifié une nouvelle modification posttraductionnelle de SIRT2, la phosphorylation de la sérine 25 (S25), ciblée spécifiquement par l'infection, et essentielle pour l'association de SIRT2 à la chromatine. Nous avons caractérisé le complexe moléculaire impliqué dans la déphosphorylation de SIRT2-S25 et nous montrons que cette modification est essentielle pour contrôler la fonction de SIRT2 en tant que répresseur transcriptionnel, et est nécessaire pour une infection efficace. Notre approche protéomique a aussi permis la caractérisation d'un interactome de SIRT2. De nombreuses protéines ont été identifiées et quelques-unes ont été confirmées et étudiées pour leur rôle dans le transport nucléo-cytoplasmique de SIRT2. De plus, une collaboration au laboratoire a mis au jour un mécanisme de subversion de la réponse aux dommages de l'ADN de l'hôte par Listeria. Dans son ensemble, ce travail a contribué à la compréhension de mécanismes originaux de l’interaction entre les bactéries et la chromatine et a révélé un processus cellulaire contrôlant la localisation subcellulaire et la fonction de la protéine de l’hôte SIRT2. / One of the best model organisms for the study of bacterial-host interactions is Listeria monocytogenes. This facultative intracellular pathogen can infect, survive, and replicate in the cytoplasm of eukaryotic cells, demonstrating the close co-evolution of Listeria with itshost. The intracellular life style of this pathogen involves manipulation of various host cellcomponents, one of which is chromatin. By inducing chromatin modifications at the level of histones, Listeria can influence the transcriptional program of the host. This thesis focuses on one specific histone modification, deacetylation of histone H3 of lysine 18, which is induced by the host deacetylase Sirtuin 2 (SIRT2) upon its relocalization from the cytoplasmto the nucleus during infection. Hijacking of SIRT2 by Listeria provides an ideal system tostudy the mechanisms of SIRT2 subcellular localization, which is poorly understood, and is the purpose of this thesis. By using mass spectrometry we have identified a novel posttranslational modification of SIRT2, Serine 25 (S25) phosphorylation, specifically targeted byinfection, and essential for SIRT2 chromatin association. We have characterized themolecular complex involved in dephosphorylating SIRT2-S25 and we show that this modification is essential for controlling SIRT2 function as a transcriptional repressor andnecessary for productive infection. Our proteomic approach further allowed the characterization of a SIRT2 interactome. Many proteins were identified and a few wereconfirmed and studied for their role in nucleo-cytoplasmic shuttling of SIRT2. In addition, a laboratory collaboration uncovered a mechanism for subversion of the host DNA DamageResponse by Listeria. As a whole, this work has contributed to the understanding of original mechanisms of chromatin-bacteria cross talk, and has revealed a cellular process controlling subcellular localization and function of the host protein SIRT2.

Le p300/CBP acétyltransférase est un co-activateur transcriptionnel très important qui est impliqué dans la régulation d'un grand nombre de processus biologiques, comme la transcription d'ADN, le développement et l'immunité innée. Jusqu'à présent, le rôle de p300/CBP dans la régulation de l'expression des gènes a été largement étudiée, mais les mécanismes qui régulent son activité enzymatique sont encore peu connus. Des études ont montré que le dysfonctionnement de p300/CBP est associé à plusieurs formes de cancer et de maladies neurodégénératives. Dés lors, chaque progrès concernant les mécanismes de régulation de p300/CBP est devenu primordial pour le développement de nouvelles thérapies. Le 'noyau' de p300/CBP contient deux domaines pour la reconnaissance des modifications post-traductionnelles (MPTs), un bromodomaine et un PHD finger (le module BP), adjacent à un domaine HAT (ou domaine histone acétyltransférase). Plusieurs enzymes, modifiant la chromatine, contiennent des domaines de reconnaissance des MPTs. Fréquemment des groupements particuliers de ces domaines sont très conservés et liés, au sein de la même protéine ou du même complexe protéique, suggérant qu'ils réalisent des fonctions coordonnées. Ces domaines adjacents peuvent agir en concertation dans la reconnaissance simultanée de différents MPTs ou peuvent exercer des fonctions différentes de celles qui sont effectuées par ces deux domaines particuliers, tels que les fonctions de régulation enzymatique. Plusieurs études suggèrent que les cycles acétylation/désacétylation dans la boucle d'auto-inhibition, à l'intérieur du domaine HAT, jouent un rôle important dans la régulation de l'activité enzymatique de p300/CBP. La proximité du module BP et du domaine HAT suggère que la spécificité de liaison, appartenant au module BP, peut être intrinsèquement liée à la régulation de l'activité du domaine HAT. L'objectif de ma thèse est de déterminer le rôle du module BP dans la régulation de l'activité du domaine HAT. Je propose que le module BP soit impliqué dans la régulation de p300/CBP de deux façons. La première consiste à établir un lien avec le domaine HAT qui stabilise la conformation auto-inhibée de l'enzyme. La deuxième exige que le module BP joue un rôle dans le choix des substrats de p300/CBP. J'ai été en mesure de montrer que BP peut se lier au domaine HAT et à la chromatine modifiée et qu'il peut reconnaître les modifications effectuées par p300/CBP lui-même. Les données obtenues indiquent que le module BP peut être impliqué dans la régulation de l'activité de p300/CBP et dans son ciblage à la chromatine.

Les facteurs de transcription de la famille Rel/NF-κB régulent l’expression d’un grand nombre de gènes impliqués dans les réponses immunitaires et inflammatoires ainsi que dans la régulation de la prolifération et de la survie cellulaire. Le caractère transitoire de l’activation de NF-κB est donc crucial pour poterger les cellules de l’autoxicité due à une trop forte expression des gènes cibles de ce facteur de transcription. Dans le cadre de notre thèse de doctorat, nous avons étudié les mécanismes moléculaires régulant la cinétique d’activation de NF-κB, en accordant une attention toute particulière au complexe kinase IKK, qui semble être le regulateur clef de l’activation de NF-κB. Nos résultats suggèrent que p300 pourrait réguler la durée d’activation des IKKs d’une part par acétylation directe, et d’autre part, indépendamment de son activité HAT, en stabilisant les IKKs et donc en prolongeant leur demie-vie et par conséquent leur activation. Certains virus utilisent la voie de signalisation NF-κB afin de promouvoir leur propre réplication. C’est le cas du virus HIV-1 (Human Immunodeficiency Virus type 1), qui contient dans son promoteur deux sites de liaison pour NF-κB. Notre laboratoire a précédemment montré que l’utilisation du TNFα en combinaison avec la TSA, active l’expression virale de manière synergique. L’administration combinée d’un activateur du facteur NF-κB et d’un inhibiteur de désacétylases pourrait, en présence d’une thérapie anti-HIV-1 efficace, être envisagée dans le but d’éliminer les cellules réservoirs infectées de manière latente. L’utilisation thérapeutique du TNFα ou de la TSA étant inenvisageable en raison de leur toxicité, nous avons étudié l’effet d’autres substances ayant un plus grand potentiel thérapeutique et nous avons apporté une preuve de principe du potentiel thérapeutique de la coadministration de plusieurs activateurs viraux (inhibiteurs de HDACs[HDACIs]+inducteurs de la voie NF-κB) pour réduire le pool des réservoirs cellulaires infectés de manière latente.